Live Stream

Transcatheter Interventions Online | Day 1 – Structural Heart Interventions


The programme aims to educate interventionalists and allied healthcare professionals on the practical implications of the latest clinical data, device selection and procedural strategies impacting optimum patient care. To further illustrate this, the event will feature a number of practical demonstrations in the form of live cases broadcast from cardiovascular centres of excellence globally, interspersed with presentations and debate sessions.

CME Accreditation

This three-day programme has been accredited by the European Board for Accreditation in Cardiology (EBAC) for a total of 12 CME points, equating to 12 hours of learning (4 hours per day). Physicians may convert EBAC External CME credits to AMA PRA Category 1 Credits™.

Each participant should claim only those hours of credit that have actually been spent in the educational activity. EBAC works according to the quality standards of the European Accreditation Council for Continuing Medical Education (EACCME), which is an institution of the European Union of Medical Specialists (UEMS).

Through an agreement between the European Board for Accreditation in Cardiology and the American Medical Association, physicians may convert EBAC External CME credits to AMA PRA Category 1 Credits™. Information on the process to convert EBAC credit to AMA credit can be found on the AMA website https://www.ama-assn.org/

Day 1 - Structural Heart Interventions

10th June 4-8pm CEST (10am – 2pm ET)

Watch on demand

Day 2: Complex & High Risk Indicated PCI

11th June 4-8pm CEST (10am – 2pm ET)

Watch on demand

Day 3: Updates on recent trials & future technologies

12th June 4-8pm CEST (10am – 2pm ET)

Watch on demand


Nicolas M Van Mieghem

Nicolas M Van Mieghem

Kendra J Grubb

Kendra J Grubb

David Hildick-Smith

David Hildick-Smith

Holger Thiele

Holger Thiele

This live stream is supported by:


4 - 5pm: PART 1.1 - TAVI Focus - 60 minutes

Intro: Nicolas Van Mieghem
SESSION CHAIRS: Nicolas Van Mieghem, Roxana Mehran
SESSION PANEL: Azeem Latib, Lars Sondergaard, Didier Tchetche, Kendra Grubb

1. Randomized TAVR/TAVI trials - How to interpret and integrate into clinical practice. How to update existing TAVR/TAVI guidelines – 10 minutes
10 minutes discussion – Nicolas Van Mieghem

2. TAVI and the conduction conundrum – 10 minutes
10 minutes discussion – Lars Sondergaard

3. TAVI in bicuspid AS – a balanced perspective – 10 minutes
10 minutes discussion – Didier Tchetche

5 - 6pm: PART 1.2 - Live TAVI Cases - 60 minutes

1. Erasmus Medical Center, NL (TAVI in Failed Bioprosthesis)

2. Brighton (TAVI in a Calcified Aorta)

6 - 7pm: PART 1.3 - Mitral & Tricuspid Focus - 60 minutes

SESSION CHAIRS: Ajay Kirtane, Azeem Latib
SESSION PANEL: Nicolas Van Mieghem, Lars Sondergaard, Kendra Grubb, Holger Thiele

1. Updated Insights on COAPT and MITRA-FR, and next steps – 10 minutes
10 minutes discussion – Nicolas Van Mieghem

2. TMVR – 10 minutes
10 minutes discussion – Kendra Grubb

3. Updated Insights on COAPT and MITRA-FR, and next steps – 10 minutes
10 minutes discussion – Nicolas Van Mieghem

7 - 7.50pm: PART 1.4 - Mitral & Tricuspid Live Cases - 50 minutes

SESSION CHAIRS: Ajay Kirtane, Azeem Latib
SESSION PANEL: Nicolas Van Mieghem, Lars Sondergaard, Kendra Grubb, Holger Thiele

1. Emory Medical Center, US (Valve in MAC post-LAMPOON)

2. Leipzig, DE (Tricuspid Edge-to-Edge Repair)

7.50pm: Wrap up of Day 1

Led by Nicolas Van Mieghem - 10 minutes

Learning Objectives

Following the activities, the participants will be able to:

  • Evaluate emerging clinical data related to interventional cardiology practice including for both devices and pharmacology
  • Recognise the latest interventional approaches for SHD and Complex PCI available for the optimal management of CV patients
  • Assess the merits of adopting emerging technologies within their practice
  • Apply the practical guidance to maximise success of their interventional procedures within TAVR, Mitral & Tricuspid Valve Replacement and Complex PCIs
  • Interact with opinion leaders in their profession

Target Audience

  • Cardiologists, interventionalists and surgeons who are involved and/or interested in transcatheter treatment strategies for coronary and structural heart disease.

Faculty Biographies

Nicolas M Van Mieghem

Nicolas M Van Mieghem

Prof Nicolas Maria Van Mieghem is an Interventional cardiologist at Thoraxcenter, Erasmus MC, Rotterdam, NL decided to pursue a career that would help others. “I enjoy the feeling of being able to help someone or do something important for them". His father was a general cardiologist and one of his biggest influences early in his career.

Prof Van Mieghem initially intended to train as a cardiac surgeon but decided to specialise in interventional cardiology instead, following advice from a mentor. This decision was cemented when he read the first-in-human case report of transcatheter aortic valve implantation (TAVI) in Circulation by Alain Cribier in 2002. Prof Van Mieghem believes that great cardiologist genuinely cares for their patients. He names Gary Roubin, Dr Manu Malbrain and Professor Patrick Serruys among his mentors. 

His current research focuses on cerebral embolic protection during TAVI and the search for improved large bore closure devices. He works actively in expanding TAVI indications, most notably TAVI as a means to further unload the left ventricle in heart failure patients with moderate aortic stenosis (the TAVR UNLOAD trial). Prof Van Mieghem is also involved in the development and dispersion of mechanical circulatory support (MCS) devices as well as transcatheter mitral and tricuspid repair techniques. In terms of imaging and preprocedural planning, his research has covered computed tomography (CT)-derived 3D modelling and printing.

As well as his involvement in percutaneous coronary interventions and structural heart programs, he has published and co-authored over 350 scientific papers in peer-reviewed journals. Professor Van Mieghem is a principal investigator and steering committee member in multiple ongoing international trials, evaluating various coronary and transcatheter valve technologies. He is a Fellow of the European Society of Cardiology (FESC) and is currently Medical Director of the department of Interventional cardiology at the Thorax Centre.

 Prof Van Mieghem is on the ICR3 Editorial Board.


View full profile

Kendra J Grubb

Kendra J Grubb

Personal History

Dr Kendra Grubb is the surgical director of the structural heart and valve center at Emory Healthcare. She is also an associate professor of surgery at Emory University School of Medicine.

Kendra is a champion for women's heart disease and is dedicated to improving the lives of all patients through innovation, collaboration and a patient-centered approach to the treatment of cardiovascular disease.


Academic History

After obtaining her BS in Biology from the University of Southern California (1999), Kendra attended the University of Southern California, where she received her a master’s in health administration from the Sol Price School of Public Policy (2001), followed by an MD degree at the Keck School of Medicine (2005).

She pursued a general surgery residency at the University of Illinois at Chicago between 2005 and 2010, a fellowship in cardiothoracic surgery at the University of Virginia in Charlottesville between 2010 and 2012, then a fellowship in interventional cardiology and transcatheter therapies at New York-Presbyterian/Columbia University Medical Center from 2012 to 2013.

Her clinical interests include valve repair or replacement, coronary artery bypass graft surgery (CABG), transcatheter aortic valve replacement (TAVR) and hybrid coronary revascularization.


Career Overview

Kendra is currently the surgical director of the Emory Structural Heart and Valve Center. Prior to joining Emory, she was the director of minimally invasive cardiac surgery and the surgical director of the heart valve program at the University of Louisville.

Kendra’s research interests are innovative cardiac surgery technologies. She has led and participated in multiple clinical trials of innovative cardiac surgery technologies, including studies of transcatheter aortic valve replacement (TAVR), MitraClip percutaneous therapy and the GORE® conformable TAG® thoracic endoprosthesis for the primary treatment of aneurysms of the descending thoracic aorta.


Career Timeline

  • 2018 - Present: Surgical Director, Structural Heart and Valve Center, Emory Healthcare
  • 2018 - Present: Associate Professor of Surgery, Division of Cardiothoracic Surgery, Department of Surgery, Emory University School of Medicine
  • Previous: University of Louisville
    • Director, Minimally Invasive Cardiac Surgery 
    • Assistant Professor, Cardiac Surgery


Areas of Speciality

  • Adult Cardiovascular Surgery
  • Hybrid Revascularization
  • Transcatheter Aortic Valve Replacement (TAVR)
  • Valvular heart disease



  • 2016: Louisville Business First, Forty Under 40
  • 2016: Teacher of the Year, Department of Cardiovascular and Thoracic Surgery, University of Louisville
  • 2015: Healthcare Innovations Award, Kentucky Life Sciences Council, MediStar Awards
  • 2015: Olga Jonasson Honored Alumnus, University of Illinois
  • 2014: Leadership Academy, American Association for Thoracic Surgery
  • 2011: Case Presentation Finalist, Mechanical Circulatory Support in Advanced Heart Failure, Thoratec
  • 2010: Thoracic Surgery Directors Association, TSDA Boot Camp Certificate of Achievement
  • 2010: Surgery Resident Teacher Award, Department of Surgery, University of Illinois at Chicago


View full profile

David Hildick-Smith

David Hildick-Smith

Prof David Hildick-Smith is Professor of Interventional Cardiology and Consultant Cardiologist at the Sussex Cardiac Centre - the Regional Specialist Unit. He is Director of the Cardiac Research, ex-Treasurer of the British Cardiovascular Interventions Society, and, with more than 20 years experience of Interventional Cardiology, is considered one of the country's leading experts in management of Cardiovascular complaints.

A pioneer of Interventional Cardiology, David is recognised internationally as a leader in cardiovascular diagnosis and treatment. 

View full profile

Holger Thiele

Holger Thiele

Dr Holger Thiele, former director and full professor in the Department of Internal Medicine/Cardiology/Angiology of the University Heart Center Lübeck at the University of Lübeck has been nominated by the faculty of the University of Leipzig as full Professor and Director of the Department of Internal Medicine/Cardiology of the Heart Center Leipzig which is affiliated with the University of Leipzig. 

View full profile